Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | MAOA | P21397 | 1/20 | 0.38 |
| ▸ | MAOB | P27338 | 1/20 | 0.38 |
| ▸ | OXTR | P30559 | 1/20 | 0.37 |
| ▸ | HTR5A | P47898 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 2/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA9 | Q16790 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19651518 | 0.80 | GAA (0.46) | GAANPSR1MAOAMAOBOXTR | |
| SCHEMBL17344772 | 0.77 | ALOX15 (0.34) | GAANPSR1MAOAMAOBOXTR | |
| SCHEMBL17344762 | 0.75 | GAA (0.41) | GAANPSR1MEN1MAPTKMT2A | |
| SCHEMBL17344796 | 0.68 | CA12 (0.47) | GAANPSR1HTR5AKMT2ACA12 | |
| SCHEMBL16306319 | 0.68 | GAA (0.56) | GAANPSR1MAOAMAOBOXTR | |
| SCHEMBL1368071 | 0.67 | GAA (1.00) | GAANPSR1MAOAMAOBOXTR | |
| SCHEMBL11195016 | 0.67 | GAA (0.60) | GAANPSR1MAOAMAOBOXTR | |
| SCHEMBL147262 | 0.67 | GAA (0.60) | GAANPSR1MAOAMAOBOXTR | |
| Hydrochloric Acid SCHEMBL11181597 | 0.66 | GAA (0.58) | GAANPSR1MAOAMAOBOXTR | |
| SCHEMBL12558458 | 0.63 | GAA (0.50) | GAANPSR1MAOAMAOBOXTR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150361093-A1 | HIV REPLICATION INHIBITOR | SHIONOGI & CO., LTD. (JP) | 2015-12-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150361093-A1 | HIV REPLICATION INHIBITOR | RTF2, REV1, PCNA | GAA 2728/4885NPSR1 3491/4885MAOA 2827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.